KR20240035488A - 섬유아세포 활성화 단백질(fap)과 결합하는 방사성 트레이서들 및 치료제들 - Google Patents

섬유아세포 활성화 단백질(fap)과 결합하는 방사성 트레이서들 및 치료제들 Download PDF

Info

Publication number
KR20240035488A
KR20240035488A KR1020247002851A KR20247002851A KR20240035488A KR 20240035488 A KR20240035488 A KR 20240035488A KR 1020247002851 A KR1020247002851 A KR 1020247002851A KR 20247002851 A KR20247002851 A KR 20247002851A KR 20240035488 A KR20240035488 A KR 20240035488A
Authority
KR
South Korea
Prior art keywords
conjugate
acid
fap
sifa
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247002851A
Other languages
English (en)
Korean (ko)
Inventor
사비투르 라흐만
로멘 베조트
구얀 리앙
압둘 카림 하지
콜린 반즈
Original Assignee
블루 어스 다이아그노스틱스 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 블루 어스 다이아그노스틱스 엘티디 filed Critical 블루 어스 다이아그노스틱스 엘티디
Publication of KR20240035488A publication Critical patent/KR20240035488A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0472—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020247002851A 2021-07-09 2022-07-08 섬유아세포 활성화 단백질(fap)과 결합하는 방사성 트레이서들 및 치료제들 Pending KR20240035488A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2109922.1 2021-07-09
GBGB2109922.1A GB202109922D0 (en) 2021-07-09 2021-07-09 Radiotracers and therapeutics binding to fibroblast activation protein (fap)
PCT/US2022/073544 WO2023283627A1 (en) 2021-07-09 2022-07-08 Radiotracers and therapeutics binding to fibroblast activation protein (fap)

Publications (1)

Publication Number Publication Date
KR20240035488A true KR20240035488A (ko) 2024-03-15

Family

ID=77353994

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247002851A Pending KR20240035488A (ko) 2021-07-09 2022-07-08 섬유아세포 활성화 단백질(fap)과 결합하는 방사성 트레이서들 및 치료제들

Country Status (7)

Country Link
US (1) US20240399001A1 (https=)
EP (1) EP4366786A1 (https=)
JP (1) JP2024529307A (https=)
KR (1) KR20240035488A (https=)
CN (1) CN117836013A (https=)
GB (1) GB202109922D0 (https=)
WO (1) WO2023283627A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024152775A1 (zh) * 2023-01-17 2024-07-25 云合智药（苏州）生物科技有限公司 缀合物、配体单元及其用途
WO2024227137A1 (en) * 2023-04-28 2024-10-31 The Board Of Regents Of The University Of Texas System Structurally-reinforced stable theranostic copper radiopharmaceuticals targeting fibroblast activation protein for cancer diagnosis and therapy
WO2025106926A1 (en) * 2023-11-16 2025-05-22 Praxis Biotech LLC Conjugates targeting fibroblast activation protein and uses thereof
WO2026041109A1 (zh) * 2024-08-23 2026-02-26 苏州博锐创合医药有限公司 成纤维细胞活化蛋白抑制剂及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116474108A (zh) 2016-12-14 2023-07-25 普渡研究基金会 成纤维细胞活化蛋白(fap)-靶向成像和治疗
HUE070098T2 (hu) 2017-07-28 2025-05-28 Univ Muenchen Tech Kettõs módusú radioaktív jelzõ és terapeutikumok
EA202090776A1 (ru) 2017-10-23 2020-07-27 Дзе Джонс Хопкинс Юниверсити Визуализирующие и радиотерапевтические агенты, нацеленные на фибробласт-активирующий белок-альфа (fapalpha)
EP3749663A1 (en) 2018-02-06 2020-12-16 Universität Heidelberg Fap inhibitor
CA3128406A1 (en) 2019-01-30 2020-08-06 Technische Universitat Munchen Cancer diagnostic imaging agents
EA202191691A1 (ru) 2019-01-30 2021-11-01 Технише Универзитет Мюнхен Радиоактивная метка, связывающая psma двумя способами, и терапевтическое средство
JP7801207B2 (ja) 2019-07-08 2026-01-16 ３ベー ファーマシューティカルズ ゲーエムベーハー 線維芽細胞活性化タンパク質リガンドを含む化合物およびその使用
FI3997103T3 (fi) 2019-07-08 2025-02-03 3B Pharmaceuticals Gmbh Fibroblastien aktivaatioproteiinin ligandia käsittäviä yhdisteitä ja niiden käyttö

Also Published As

Publication number Publication date
US20240399001A1 (en) 2024-12-05
CN117836013A (zh) 2024-04-05
WO2023283627A1 (en) 2023-01-12
JP2024529307A (ja) 2024-08-06
EP4366786A1 (en) 2024-05-15
GB202109922D0 (en) 2021-08-25
WO2023283627A9 (en) 2023-03-02

Similar Documents

Publication Publication Date Title
KR20240035488A (ko) 섬유아세포 활성화 단백질(fap)과 결합하는 방사성 트레이서들 및 치료제들
AU2019225154B2 (en) Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
ES2648096T3 (es) Radiofármacos a base de triazina y agentes de radioformación de imágenes
ES2990974T3 (es) Conjugados de folato de entidades fijadoras de albúmina
KR20230118160A (ko) 섬유아세포 활성화 단백질 억제제
EP2536691B1 (en) Bifunctional chelating agents
KR20230162589A (ko) 이중 모드 방사성 트레이서 및 -치료제
US20190142977A1 (en) GADOLINIUM-BASED CONTRAST AGENTS FOR SENSITIVE DETECTION OF Zn2+ WITH MRI
JP7771080B2 (ja) 医薬配合物
JP2026508513A (ja) 窒素含有複素環系化合物およびその製造方法と使用
JP2004537573A (ja) 心臓灌流およびビトロネクチン受容体を標的とするイメージング剤の同時イメージング
CN117279930A (zh) 三官能化合物和其用途
KR20230160806A (ko) 이중 모드 방사성 트레이서 및 치료법
KR101861025B1 (ko) 영상화 제제로서의 ｎ-알콕시아미드 접합체
Singh et al. A homodimeric bivalent radioligand derived from 1-(2-methoxyphenyl) piperazine with high affinity for in vivo 5-HT1A receptor imaging
CN120829485A (zh) 双重靶向成纤维细胞激活蛋白和整合素亚型的化合物及其制备和应用
WO2024037635A1 (en) A trifunctional compound and use thereof
TW202428306A (zh) 神經肽y1受體(npy1r)靶向治療劑及其用途
KR20250065366A (ko) 방사성핵종 조성물 및 이를 이용한 종양세포 검출 방법
MXPA01006151A (en) Vitronectin receptor antagonist pharmaceuticals

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-EXM-PA0201 (AS PROVIDED BY THE NATIONAL OFFICE)

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201